Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coolen

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|February 24, 2015
Bridging topological and functional information in protein interaction networks by short loops profilingSun Sook Chung, Alessandro Pandini, Alessia Annibale, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 5, 2006
From CBCL to DSM: a comparison of two methods to screen for DSM-IV diagnoses using CBCL dataNicole P C M Krol, Eric E J De Bruyn, Jolanda C Coolen, et al.
Thymus|January 1, 1989
Defects in the thymic epithelial stroma of diabetes prone BB ratsJ Rozing, C Coolen, F J Tielen, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Journal of Clinical Microbiology|February 23, 2007
Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapyJ M Carr, K M Cheney, C Coolen, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohortG George, M Rowley, A C C Coolen, et al.
Journal of Medicinal Chemistry|September 21, 2007
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugsJos H M Lange, Jan-Hendrik Reinders, Jeroen T B M Tolboom, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
BMC Cancer|November 19, 2015
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysisWahyu Wulaningsih, Mariam Vahdaninia, Mark Rowley, et al.
Journal of Medicinal Chemistry|January 6, 2010
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonismJos H M Lange, Hein K A C Coolen, Martina A W van der Neut, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|February 24, 2015
Bridging topological and functional information in protein interaction networks by short loops profilingSun Sook Chung, Alessandro Pandini, Alessia Annibale, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|January 5, 2006
From CBCL to DSM: a comparison of two methods to screen for DSM-IV diagnoses using CBCL dataNicole P C M Krol, Eric E J De Bruyn, Jolanda C Coolen, et al.
Thymus|January 1, 1989
Defects in the thymic epithelial stroma of diabetes prone BB ratsJ Rozing, C Coolen, F J Tielen, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Journal of Clinical Microbiology|February 23, 2007
Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapyJ M Carr, K M Cheney, C Coolen, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohortG George, M Rowley, A C C Coolen, et al.
Journal of Medicinal Chemistry|September 21, 2007
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugsJos H M Lange, Jan-Hendrik Reinders, Jeroen T B M Tolboom, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
BMC Cancer|November 19, 2015
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysisWahyu Wulaningsih, Mariam Vahdaninia, Mark Rowley, et al.
Journal of Medicinal Chemistry|January 6, 2010
Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonismJos H M Lange, Hein K A C Coolen, Martina A W van der Neut, et al.
Pageof 6